Published in J Chem Neuroanat on March 01, 2003
Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias. Am J Alzheimers Dis Other Demen (2010) 0.95
Striatal cholinergic interneuron regulation and circuit effects. Front Synaptic Neurosci (2014) 0.91
Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT. J Neurol (2007) 0.87
Cerebral amyloid angiopathy in Lewy body disease. J Neural Transm (Vienna) (2008) 0.81
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats. Br J Pharmacol (2005) 0.80
M1 muscarinic receptor for the development of auditory cortical function. Mol Brain (2010) 0.79
The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases. J Neurol Neurosurg Psychiatry (2006) 0.77
Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT. J Neurol (2015) 0.76
Magnetic resonance spectroscopy in the diagnosis of dementia with Lewy bodies. Biomed Res Int (2014) 0.76
Neuroprotective effects of tadalafil on gerbil dopaminergic neurons following cerebral ischemia. Neural Regen Res (2013) 0.75
Striatal input- and rate-dependent effects of muscarinic receptors on pallidal firing. ScientificWorldJournal (2012) 0.75
Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease. J Neural Transm (Vienna) (2016) 0.75
Muscarinic receptor binding changes in postmortem Parkinson's disease. J Neural Transm (Vienna) (2016) 0.75
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet (2006) 6.52
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet (2011) 6.09
Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med (2012) 5.64
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol (2006) 4.24
A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol (2011) 4.15
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol (2008) 4.14
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol (2007) 3.25
Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A (2011) 3.23
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann Neurol (2003) 2.61
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis (2006) 2.42
Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann Neurol (2009) 2.21
Frontotemporal dementia in elderly individuals. Arch Neurol (2012) 2.21
Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr (2011) 2.16
Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry (2002) 1.96
Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry (2002) 1.88
Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids. Neuron (2007) 1.85
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. Am J Psychiatry (2004) 1.82
Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging (2011) 1.73
Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care (2008) 1.67
Can a tool that automates insulin titration be a key to diabetes management? Diabetes Technol Ther (2012) 1.63
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol (2005) 1.62
The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons. J Neurosci (2013) 1.59
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. BMJ (2005) 1.54
alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol (2004) 1.53
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med (2007) 1.52
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry (2007) 1.52
Antipsychotics for people with dementia. BMJ (2008) 1.45
alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases. Acta Neuropathol (2004) 1.43
Implementation of a telepharmacy service to provide round-the-clock medication order review by pharmacists. Am J Health Syst Pharm (2010) 1.43
Dopamine-stimulated dephosphorylation of connexin 36 mediates AII amacrine cell uncoupling. J Neurosci (2009) 1.43
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? Cerebrovasc Dis (2011) 1.40
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol (2004) 1.33
Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol (2010) 1.31
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol (2006) 1.29
Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett (2003) 1.27
Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord (2003) 1.27
White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke (2004) 1.26
Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatry (2010) 1.26
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav (2003) 1.25
Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study. Cerebrovasc Dis (2009) 1.25
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord (2014) 1.21
Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis (2006) 1.20
Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathol (2010) 1.19
The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol (2011) 1.18
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry (2007) 1.17
Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study. J Neuropathol Exp Neurol (2012) 1.17
Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med (2007) 1.16
Connexin 35/36 is phosphorylated at regulatory sites in the retina. Vis Neurosci (2007) 1.15
Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial). Am J Geriatr Psychiatry (2009) 1.14
Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry (2005) 1.11
Photoreceptor coupling is controlled by connexin 35 phosphorylation in zebrafish retina. J Neurosci (2009) 1.11
Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia (2003) 1.08
Construction of a 'unigene' cDNA clone set by oligonucleotide fingerprinting allows access to 25 000 potential sugar beet genes. Plant J (2002) 1.08
Is late onset depression a prodrome to dementia? Int J Geriatr Psychiatry (2002) 1.08
Adenosine and dopamine receptors coregulate photoreceptor coupling via gap junction phosphorylation in mouse retina. J Neurosci (2013) 1.07
Protein kinase A mediates regulation of gap junctions containing connexin35 through a complex pathway. Brain Res Mol Brain Res (2005) 1.07
Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis (2006) 1.06
Mild cognitive impairment should be considered for DSM-V. J Geriatr Psychiatry Neurol (2006) 1.06
Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID). Neurobiol Aging (2005) 1.04
MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study. Cerebrovasc Dis (2009) 1.04
Regulation of gap junction coupling through the neuronal connexin Cx35 by nitric oxide and cGMP. Cell Commun Adhes (2006) 1.03
Sensory neuronopathy in patients harbouring recessive polymerase γ mutations. Brain (2011) 1.03
Molecular and functional asymmetry at a vertebrate electrical synapse. Neuron (2013) 1.03
Multiple neuronal connexins in the mammalian retina. Cell Commun Adhes (2003) 1.02
Nonsynaptic NMDA receptors mediate activity-dependent plasticity of gap junctional coupling in the AII amacrine cell network. J Neurosci (2012) 1.02
Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc (2006) 1.01
Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta Neuropathol (2011) 1.01
Regulation of neuronal connexin-36 channels by pH. Proc Natl Acad Sci U S A (2008) 1.00
An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects. J Gene Med (2004) 1.00
Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study. J Am Geriatr Soc (2008) 1.00
Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J Neurochem (2002) 0.99
Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. Biol Psychiatry (2003) 0.99
Coupling between A-type horizontal cells is mediated by connexin 50 gap junctions in the rabbit retina. J Neurosci (2006) 0.99
Vascular basis of late-onset depressive disorder. Br J Psychiatry (2002) 0.98
Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiol Dis (2012) 0.98
Molecular characterization of the skate peripherin/rds gene: relationship to its orthologues and paralogues. Invest Ophthalmol Vis Sci (2003) 0.97
Calcium-dependent binding of calmodulin to neuronal gap junction proteins. Biochem Biophys Res Commun (2005) 0.96
Efficient depletion of host DNA contamination in malaria clinical sequencing. J Clin Microbiol (2012) 0.96
Deterioration of gait and balance over time: the effects of age-related white matter change--the LADIS study. Cerebrovasc Dis (2013) 0.96
Profile of neuropsychological deficits in older stroke survivors without dementia. Dement Geriatr Cogn Disord (2003) 0.95
A review of acrylamide: an industry perspective on research, analysis, formation, and control. Crit Rev Food Sci Nutr (2004) 0.95
Dementia with Lewy bodies. Semin Clin Neuropsychiatry (2003) 0.94